Zou L X, Hymel A, Imig J D, Navar L G
Department of Physiology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Hypertension. 1996 Mar;27(3 Pt 2):658-62. doi: 10.1161/01.hyp.27.3.658.
Previous studies have demonstrated that low-dose angiotensin II (Ang II) infusion for 14 days mimics two-kidney, one clip Goldblatt hypertension and increases intrarenal Ang II levels. The objective of the present study was to determine whether the augmented intrarenal Ang II is due to intrarenal accumulation of the infused Ang II and/or to an increase in intrarenal formation of endogenous Ang II. Male Sprague-Dawley rats were uninephrectomized and divided into three groups: control (N=6), those infused with [Ile5]Ang II (endogenous form) (N=6), and those infused with [Val5]Ang II (n=8). [Ile5]Ang II or [Val5]Ang II was infused at 40 ng/min via an osmotic minipump implanted subcutaneously. By day 12, systolic blood pressure increased significantly in both [Val5]Ang II-infused rats (197 +/- 7 mm Hg) and [Ile5]Ang II-infused rats (173 +/- 3 mm Hg). Blood and kidney samples were harvested, subjected to high-performance liquid chromatography to separate [Val5]Ang II from [Ile5]Ang II, and then measured by radioimmunoassay. Plasma renin activity was markedly suppressed in both [Ile5]Ang II- and [Val5]Ang II-infused rats. Plasma Ang II levels were elevated in rats infused with both [Ile5]Ang II (121 +/- 24 fmol/mL) and [Val5]Ang II (119 +/- 14 fmol/mL) compared with controls (69 +/- 15 fmol/mL). Both [Ile5]Ang II- and [Val5]Ang II-infused rats exhibited an enhancement of total intrarenal Ang II. Only [Ile5]Ang II (358 +/- 53 fmol/g) was detected in the kidneys of rats infused with -Ile5-Ang II. In [Val5]Ang II-infused rats, a significant portion of total renal Ang II (371 +/- 57 fmol/g) was in the form of [Val5]Ang II (256 +/- 44 fmol/g). Renal [Ile5]Ang II levels were maintained in the [Val5]Ang II-infused rats (116 +/- 15 fmol/g) compared with control rats (116 +/- 11 fmol/g) despite marked suppression of renin release. These results support the hypothesis that infused circulating ANG II is bound to receptor or taken up intrarenally in a manner that protects against degradation.
先前的研究表明,低剂量输注血管紧张素II(Ang II)14天可模拟二肾一夹型肾血管性高血压,并增加肾内Ang II水平。本研究的目的是确定肾内Ang II增加是由于输注的Ang II在肾内蓄积和/或肾内源性Ang II生成增加所致。将雄性Sprague-Dawley大鼠单侧肾切除,并分为三组:对照组(N = 6)、输注[Ile5]Ang II(内源性形式)的大鼠(N = 6)和输注[Val5]Ang II的大鼠(n = 8)。通过皮下植入的渗透微型泵以40 ng/分钟的速度输注[Ile5]Ang II或[Val5]Ang II。到第12天,输注[Val5]Ang II的大鼠(197±7 mmHg)和输注[Ile5]Ang II的大鼠(173±3 mmHg)的收缩压均显著升高。采集血液和肾脏样本,通过高效液相色谱法将[Val5]Ang II与[Ile5]Ang II分离,然后通过放射免疫测定法进行测量。输注[Ile5]Ang II和[Val5]Ang II的大鼠的血浆肾素活性均明显受到抑制。与对照组(69±15 fmol/mL)相比,输注[Ile5]Ang II(121±24 fmol/mL)和[Val5]Ang II(119±14 fmol/mL)的大鼠的血浆Ang II水平均升高。输注[Ile5]Ang II和[Val5]Ang II的大鼠的肾内总Ang II均增强。在输注-Ile5-Ang II的大鼠肾脏中仅检测到[Ile5]Ang II(358±53 fmol/g)。在输注[Val5]Ang II的大鼠中,肾内总Ang II的很大一部分(371±57 fmol/g)为[Val5]Ang II(256±44 fmol/g)形式。尽管肾素释放明显受到抑制,但与对照大鼠(116±11 fmol/g)相比,输注[Val5]Ang II的大鼠的肾内[Ile5]Ang II水平保持不变(116±15 fmol/g)。这些结果支持以下假设:输注的循环ANG II与受体结合或以防止降解的方式被肾内摄取。